Nativis, Inc. Convenes Inaugural Ultra-Low Radio Frequency Energy Technology Advisory Board (TAB) Meeting Post author:Sam Post published:March 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Why This Heart Drug Could Be a $5B Blockbuster for Novartis January 23, 2018 Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017 A Look at the Deaths That Plagued Juno and Kite Pharma's CAR-T Trials June 26, 2017
Sangamo Receives Fast Track Designation From The FDA For SB-318 And SB-913 In Vivo Genome Editing Product Candidates For The Treatment Of MPS I And MPS II July 13, 2017